Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0207. Online ahead of print.
JAMA Oncol. 2024.
PMID: 38573643
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report.
Broudic-Guibert M, Blay JY, Vazquez L, Evrard A, Karanian M, Taïeb S, Hoog-Labouret N, Oukhatar CMA, Boustany-Grenier R, Arnaud A.
Broudic-Guibert M, et al. Among authors: boustany grenier r.
J Med Case Rep. 2019 Jul 25;13(1):245. doi: 10.1186/s13256-019-2140-6.
J Med Case Rep. 2019.
PMID: 31340860
Free PMC article.
Item in Clipboard
Cite
Cite